Epidemiology Classification Review the terminology used to discuss anemia Evaluation Address clues in the history and exam that can direct the evaluation Describe one approach to using lab tests to make the diagnosis ID: 911483
Download Presentation The PPT/PDF document "Anemia Goals Definition of anemia" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Anemia
Slide2Goals
Definition of anemia
.Epidemiology.Classification. Review the terminology used to discuss anemia.Evaluation:.
• Address clues in the history and exam that can direct the evaluation. • Describe one approach to using lab tests to make the diagnosis. Review some anemia& aspects of treatment of common anemia.
Slide3Definitions
A.
Anemia refers to a reduction in the number or volume of RBCs to less than a normal level. May occur due to: Acute/chronic blood loss Decreased production Breakdown of blood (hemolysis)
Slide4B
.
Strictly defined by decreased Hgb relating to a value 2SD below a mean .
Slide5AGE
Hgb
Mean/ (-2SD)
HCT%
Mean/ (-2SD)
MCV
Mean/ (-2SD)
Newborn
16.5 (13.5)
51 (42)
108 (96)
1 Month13.9 (10.7)44 (33)101 (91) 2 Months11.2 (9.4) 35 (28)95 (84) 6 Months12.6 (11.0)36 (31)76 (68) > 6 Months12.5 (11.0)36 (33) 81 (70+ age per yr)AdultMaleFemale15.5 (13.5)14.0 (12.0)47 (40)41 (36)90 (80) 90 (80)
1. Normal values vary according to age and gender (and lab)
Slide62 . Specific lab values must be interpreted in context of :
patient and illness;
ie, are Hgb levels of 14.0 in a male smoker, or of 12.5 in a severely volume contracted woman, “normal?”
Slide7C.
The clinical context and condition of the patient
determine how urgently Dx and Rx must occur.
Slide8EPIDEMIOLOGY
Anemia affects more than 2 billion people worldwide – one-third of the world's population.
Half of these are iron deficiency anemia.
Anemia is common in menstruating women,infant, children and elderly patients.In almost all developing countries, at least 1/3 of the Women and children are anemic.Prevalence among pregnant women and children under 2 years of age is more than 50 %.
Anemia contributes to 20% of all maternal deaths.
Slide9Indices
1. Hgb – most reliable value 2. Hct – reliable if spun; if automated it is an approximation. 3. MCV (mean corpuscular volume) – is a useful index for distinguishing anemias (if homogenous RBC population).
• Normal MCV 82-97 fL • Macrocytosis > 97 fL • Microcytosis < 82 fL
Slide10Mentzer
index = MCV/RBC
Ratio <13: Thalassemia Ratio >13: Iron Deficiency Anemia, Hemoglobinopathy.
Mean corpuscular hemoglobin (MCH) - Average quantity of Hb per red cell MCH (pg) = (Hb x 10) ÷ RBC
Slide114. MCHC (mean corpuscular
Hgb
concentration) – derived index Grams of hemoglobin per 100 cc packed cells. MCHC = (Hb ÷ PCV) x 100 5. RDW (red blood cell distribution width) – calculated index (
nml 11.5-14.5%); if elevated, indicates variability of RBC (anisocytosis) – unreliable value in diagnosis.It measures RBC size variation (Anisocytosis)Standard deviation of RBC volume x 100
MCV
It is very helpful to distinguish between different types of
microcytic
anemia.
Slide12Reticulocyte
Count:
Decreased:1- Hypoproliferative
2- ineffective erythropoiesisIncreased :1 -Iron deficiency anemia
2 Lead poisoning
3 Condition with high
reticulocyte
count (
thalassemia
minor?)
4
Erythropoietic porphyria5 Inflammation
Slide13Slide14E. Remember the value and often the need, to actually examine the peripheral smear Spherocytes/ovalocytes Sickle cells
Schistocytes – traumatic hemolysis (prosthetic valve, DIC, TTP, hemolytic-uremic syndrome) “Teardrop” cells – bone marrow disease (fibrosis, tumor) Oval macrocytes,
hypersegmented
polys
–
megaloblastic
anemia
Immature (blast) cells – leukemia
Slide15Slide16RBC MORPHOLOGY ON A PERIPHERAL SMEAR
Slide17classification
Morphologic
MCV,MCHC,RDWFunctionalDecrease productionIncrease destructionUnderlying mechanismImpaired production(proliferation ,differentiation ,maturation )
Increased destruction-hemolytic.Blood loss.
Slide18MORPHOLOGICAL CLASSIFICATION OF ANEMIAS
Slide19Anemia
Microcytic
anemia
(MCV<80)
Normocytic
anemia
(MCV 80–100)
Macrocytic anemia
(MCV>100)
High
reticulocyte
countLow reticulocyte countWith megaloblastic bone marrowWithout megaloblastic bone marrow
Slide20Slide21Slide22Functional classification
I.
inadequate production of RBCs :
A. deficiency of essential factors
B. toxic factors
C. endocrine causes (thyroid ,pituitary)
D.
erythropoiten
production (renal, starvation)
E. invasion of bone marrow
f. failure of stem cells
II. Increased RBC loss or destruction (hemolytic anemia)III. Blood loss anemia
Slide23FUNCTIONAL CLASSIFICATION OF
ANEMIAS
Slide24II.
Evaluation
Slide25A.
History
1. Hx of chronic anemia or family Hx of anemia – may suggest inherited anemia. Spherocytosis
, ovalocytosis Hemoglobinopathy 2. Medical Hx – many chronic illnesses can be associated with anemia.
Chronic infection
Diabetes, hypothyroid, renal,
hypoadrenal
, collagen
vascular diseases are common causes.
Malignancy
Slide263. Social
Hx
Nutritional: strict vegan (B12); few fruits/veggies (folate) Alcohol use (folate, marrow suppression, liver disease) .4. Surgical Hx
: partial or total gastrectomy.
Slide275. Medications can cause
Bone marrow depression
Hemolysis (G-6-PD deficiency) 6. Review of systems Pregnancy Menses Symptoms suggesting undiagnosed medical problem
Slide28B.
Symptoms attributable to anemia alone
1. Usually not present until Hgb level less than 7-8 g/dl. 2. No correlation between level and signs/symptoms.
Slide29C.
Physical findings
1. Pallor of oral mucosa/conjunctiva 2. Palmar crease pallor suggests Hgb < 7 g/dl.
Slide303.
Volume status:
orthostasis, baseline tachycardia, widened pulse pressure, flow murmurs, flat neck veins, decreased urine output, decreased turgor. 4. Skin: jaundice (hemolysis),
petechiae/ecchymoses (bleeding disorders), lymphadenopathy (malignancy/infection)
Slide315. Oral
• Glossitis, macroglossia (pernicious anemia) • Angular cheilitis (Fe deficiency)
Glossitis
Angular
Stomatitis
Slide32Angular
Stomatitis
Koilonychia
Slide336.
Neuro: paresthesias, dementia, ataxia, decreased proprioception/vibration (pernicious anemia). 7. Heme positive stool (GI loss).
8. Splenomegaly (hemolysis, sequestration, malignancy).
Slide34The symptoms can be related to the anemia itself, or the underlying cause:
fatigue.
Dizziness.
headache.
poor concentration
Parasthesia
in fingers and toes.
Irritability
dyspnea. increasing cardiac output: palpitation , intermittent claudication and symptoms of heart failure .Symptoms
Slide35D.
Labs
1. Approach varies greatly depending upon reference, experience, circumstances, etc; regardless of approach, have a rationale for it. Recognize the difference between patient in office vs in hospital (usually acutely ill).
Try not to “shotgun” (even though we all do it!)
Slide362.
Approach
a. CBC, peripheral smear b. Check retic count 1) Must calculate the corrected absolute
retic count • Abs retic count = retic count x RBC • Abs retic
count
<
100,000 suggests
defect
inRBC
production
•
Abs retic count > 100,000 suggests acute bleeding or hemolysis
Slide372) Corrected Abs
retic
count = Abs retic count/retic maturity time • Hct 45% Mat time 1 day • Hct 25%, 2.0 days •
Hct 15%, 2.5 days
Slide38c.
Use MCV and
retic count to determine path for workup
Slide39Anemia
Microcytic
anemia
(MCV<80)
Normocytic
anemia
(MCV 80–100)
Macrocytic anemia
(MCV>100)
High
reticulocyte
countLow reticulocyte countWith megaloblastic bone marrowWithout megaloblastic bone marrow
Slide403). Specific notes
a.
Serum Fe: negative phase reactant – it decreases with any stress (fever, etc).b. TIBC: only elevated in Fe def; however, it is also a negative acute phase reactant.
c. % Sat: decreases in both Fe def and ACD
Slide41d.
Ferritin
: proportional to body’s iron stores generally both increase with age. Less than 16-35 ng/dl suggests depleted stores (if older than 65, less than 45 ng/dl).
Even though it is a positive acute phase reactant, must have Fe to elevate. Can have ferritin of 50-60 ng/mL and still have Fe deficiency.
e.
Bone marrow
iron stores: (gold standard).
Slide42Microcytic
AnemiasDIFFERENTIAL DX:
Iron Deficiency AnemiaThalassemiasSideroblastic Anemia
Lead poisoning
Anemia of chronic disease (usually
normocytic
)
MCV < 80
Check also MCH, MCHC, RDW
Next Lab
testsIron studies Serum Iron TIBC/transferrin Serum Ferritin, % sat
Slide43Microcytic
Anemia (MCV < 82
fL)1. Check ferritin level a. Low value (generally < 30 ng/
mL) suggests/confirms iron def. b. Normal or high value – check serum iron. 1) Low Fe – anemia of chronic disease (ACD) 2) Normal or increased – check serum lead level. • High – lead toxicity • Normal – do Hgb
electrophoresis:
thalassemia
Slide44Iron Deficiency Anemia
Most common cause of anemia worldwide
1. Prevalence:10-25% young women, 1% men, up to 10% elderly 2. Why worry? a. Treatable b. Clue to underlying diseases
• 10-20% pts w/Fe def anemia have CA. • Up to 50% have GERD/PUD 3. Diet 10-15 mg/day – 10% absorbed
Slide454
. Daily loss 1 mg/d, plus 1 mg/d menstruation
5. FeSO4 20% elemental iron: 180 mg = 36 mg elemental Fe 6. Replace Fe at 6 mg/kg/day up to 200 mg/d elemental Fe 7. Consider Feosol elixir to minimize GI side effects common with FeSO4 tablets.
Slide46Iron deficiency anemia
Iron deficiency anemia is the most common type of anemia
Slide478.
Vitamin C increases absorption of non-
heme Fe; literature implies little clinical significance, but antioxidant Rx is becoming a hot topic. 9. Retic count up by 2 weeks 10. Anemia corrected by 6 weeks 11.
4-6 months to correct depleted Fe stores of 500 mg 12. In questionable cases, especially of distinguishing Fe-def vs ACD in an elderly ill patient, consider empiric trial of Fe replacement. Be sure to follow retic and Hgb
; if no
change, stop Fe
Slide48PREVALENCE OF ID
Region
0-4yr 5-12yr
WomenSouth Asia 56% 50% 58%
Africa
56% 49% 44%
Latin Am
26% 26% 17%
Gulf Arabs
40% 36% 38%
Developed
12% 7% 11% World 43% 37% 35%
Slide49Causes of iron-deficiency anemia
1. Increased need Pregnancy Normal growth 2. Decreased intake or absorption Childhood Gastric surgery, achlorhydria
Celiac sprue 3. Increased blood loss GERD, PUD, gastritis IBD Malignancy Menstruation
Slide50Clinical Signs to be looked for
Skin / mucosal pallor,
Skin dryness, palmar creases
Bald tongue, GlossitisMouth ulcers, Rectal exam
Jaundice,
Purpura
Lymph
adenopathy
Hepato-splenomegaly
Breathlessness
Tachycardia, CHF
Bleeding, Occult Blood
Slide51TREATMENT:
Oral iron replacement (ferrous sulfate)
Side effects: constipation, nausea, dyspepsiaIV or IM iron dextran—
If pt cannot tolerate PO, poor PO absorption, or greater requirements than PO can provideBlood transfusion—NOT recommended unless anemia is severe or pt has cardiopulmonary disease
Slide52Short term prevention of IDA in infancy
Avoid gestational ID
Try to prevent premature delivery and LBW (pregnancy care)
Increase birth spacingBreast feeding also reduces or delays the onset of IDAIron supplement after 6 months
Slide53Slide54Slide55Thalassemia
Inherited disorders
Classified according to deficient chain, severity varies based on mutationsα
-thalassemiaβ-thalassemia
Inadequate production of either the alpha- or beta-
globin
chain of
Hb
Microcytic
,
hypochromic
RDW usually normalHigh RBC countCan see tear drop cells, target cellsNormal or increased ironDx by Hb electrophoresis“Thalassa” means “sea” in Greek
Slide56Slide57Slide58Slide59Slide60Slide61Normocytic
AnemiasDIFFERENTIAL DX:Anemia of chronic disease
Aplastic AnemiaRenal, liver, or endocrine disease
Slide62Normocytic Anemia (MCV 82-97
fL) 1. Check corrected absolute reticulocyte count a. Low or normal 1) Any changes of marrow failure
a) Yes – do bone marrow biopsy • Myelodysplasia • Infiltrative disease • Aplastic anemia b) No – Dx is ACD.
Slide63b. High
1) Check LDH,
haptoglobin Normal – can be expected response to blood loss. Abnormal – check Coombs’
Slide642) Any
splenomegaly
? a) Yes – check RBC morphology and Coombs’ • Negative Coombs’ – hypersplenism, drug effect, infection, hemoglobinopathy • Positive Coombs’ – hemolytic disease b) No – hemolytic disease
Slide65Causes
1. Decreased RBC production Bone marrow failure Aplastic anemia 2. RBC destruction/loss a. Acute blood loss (may be occult) b. Hypersplenism
c. Hemolytic anemia 1) Intrinsic RBC anomalies • Spherocytosis • G6PD defects • Hemoglobinopathies
2) Extrinsic factors
• Mechanical
• Infectious (DIC)
• Autoimmune antibodies
Slide66Slide67Slide68Slide69Aplastic
Anemia
RareLow reticulocyte % accompanied by pancytopenia
Causes:Idiopathic (majority)Congenital—Fanconi
anemia
Radiation exposure
Meds—
chloramphenicol
, sulfonamides, gold,
carbamazepine
Viral infection—human parvovirus,
HepB, HepC, EBV, CMV, HZV, HIVChemicals—benzene, insecticides
Slide70Aplastic
Anemia
Clinical:Fatigue, dyspnea, petechiae
, easy bruising, frequent infectionsCan transform into acute leukemiaDiagnosis: Bone marrow biopsy—definitive—hypocellular marrow, absence of progenitors
Treatment:
Bone marrow transplant, transfuse with PRBCs and platelets if necessary,
immunosuppression
Slide71Treatment
Directed at cause
If ACD, iron replacement doesn’t help and may be detrimental. Consider erythropoietin
Slide72Macrocytic
AnemiasDIFFERENTIAL DX:
Vitamin B12 Deficiency (MCV>115)Folate Deficiency (MCV>115)Liver disease (MCV up to 115)
Stimulated
erythropoiesis
(MCV up to 110)
MCV > 100
Next labs to check:
serum
vit
B12 serum folate serum homocysteine serum methylmalonic acid Intrinsic factor Ab
Slide73Macrocytic
Anemia (> 97 fL
) 1. Evaluate peripheral smear for macrocytes,
hypersegmented polys a. Present – megaloblastic anemia
1) Check B12,
folate
levels
• One or both low – deficiency (replace): consider
Schilling’s test.
• Normal – consider due to drug or idiopathic:
referral for
eval, bone marrow
Slide74Slide75b. Absent –
nonmegaloblastic
anemia 1) Review Abs corrected retic count a) Low or normal • Eval for liver disease, hypothyroidism • If absent, aplastic
anemia b) High • Hemolytic disease • Acute blood loss • Hypersplenism
Slide762
.
Many drugs can cause macrocytosis without megaloblasts. • Phenytoin, OCs, MTX, barbiturates, TMP-SMX,
zidovudine • Alcohol is the most common cause of macrocytosis.
Slide77Vitamin B
12
DeficiencyCauses—
most due to poor absorptionPernicious anemia (lack of intrinsic factor)GastrectomyPoor diet
Alcoholism
Crohn’s
disease,
ileal
resection
Organisms competing for
Vit
B12If untreated can lead to demyelination in posterior columns, lateral corticospinal tracts, spinocerebellar tracts
Slide78Causes of B12 deficiency
Slide79Vitamin B
12
DeficiencyDiagnosis:Peripheral blood smear—macrocytic
RBCs, hypersegmented neutrophilsLow serum vitamin B
12
(<100pg/
mL
)
Methylmalonic
acid,
homocysteine
levels are elevatedShilling testTreatment:Cyanocobalamin (vit B12) IM once per month
Slide80Slide81Normochromic, Macrocytic, hypersegmentation of nuetrophils
Slide82Folate
Deficiency
Stores are limited, can become depleted over 3 month periodMain source—green vegetablesCauses—“tea and toast” diet, alcoholism, long term oral antibiotic use, increased demand, pregnancy,
hemolysis, methotrexate use, anticonvulsants (phenytoin), hemodialysis
Clinical—similar to
Vit
B
12
deficiency, without the neurologic symptoms
Treat—daily oral folic acid replacement
Slide83Causes of
folate
deficiency
Slide84Slide85Sideroblastic
Anemia
Caused by abnormality in RBC iron metabolismHereditary or acquiredAcquired causes include drugs, lead exposure, collagen vascular disease,
neoplastic diseaseLab findings: normal or increased serum iron and ferritin
normal TIBC
ringed
sideroblasts
in bone marrow
normal RDW
Treatment: remove offending agents, consider pyridoxine (Vit.B6)
Slide86Lead Poisoning
One cause of
sideroblastic anemiaCommon in children
May cause microcytosis if lead level in blood >100µg/dL
(could also be
normocytic
)
Can see basophilic stippling
If lead levels 45-69µg/
dL
:Find and remove lead sourceAdminister EDTA 5.0mg/kg in two divided doses, slow IV infusion for 5 days, ample fluidsAlternative—DMSA—orally acting chelating agent, for use in childrenUse both agents if level >69µg/dL
Slide87Treatment
1. Must be tailored to cause
2. Replacement • Folic acid: 1 mg/d • Vit B12: 1000 microgram/d IM for 5 days, then q week until Hct normal, then q month for life (some studies
suggest p.o. replacement as effective)
Slide883. Discontinue offending drugs/agents.
4. Transfusion
a. Avoid transfusion “triggers.” b. Plan for autologous blood if possible. c. Administer unit-by-unit based on reassessment. d. Transfuse to relieve symptoms related to blood loss when other replacement has failed.
• Syncope • Dyspnea • Shock • Angina/TIA
Slide89HYPOCHROMIC, MICROCYTIC ANEMIAS
Slide90NORMOCHROMIC, NORMOCYTIC ANEMIAS
Slide91MACROCYTIC ANEMIAS
Slide92Thank You ALL